Potassium%2525252525252525252525252525252525252525252525252525252525252520chloride

## Potassium Chloride ### Overview Potassium chloride (KCL) is an electrolyte supplement used to treat or prevent hypokalemia. It is available in oral and intravenous formulations. ### Primary Indications * Treatment and prevention of hypokalemia. ### Adult Dosing * **Oral:** * Prevention: 20 mEq (1.5 g) to 40 mEq (3 g) per day, divided into 1 to 4 doses. * Treatment: 40 mEq (3 g) to 100 mEq (7.5 g) per day, divided into 3 to 5 doses. Maximum daily dose generally should not exceed 100 mEq to 120 mEq. Dosing depends on severity of hypokalemia and patient response. * **Intravenous (IV):** * Concentration: Infusions should generally not exceed 40 mEq/L in peripheral lines and 80 mEq/L in central lines to minimize phlebitis and pain. * Rate: Maximum infusion rate is typically 10 mEq/hour. Higher rates (up to 20 mEq/hour or more) may be used in severe, symptomatic hypokalemia or in a critical care setting with continuous ECG monitoring, as per local protocol. Dosing depends on severity of hypokalemia and patient response. ### Pediatric Dosing * **Oral:** * Prevention: 1 mEq/kg/day to 2 mEq/kg/day, divided into 1 to 2 doses. Maximum daily dose typically 3 mEq/kg/day or 40 mEq/day, whichever is less. * Treatment: 2 mEq/kg/day to 4 mEq/kg/day, divided into 3 to 4 doses. Maximum daily dose typically 6 mEq/kg/day or 100 mEq/day, whichever is less. Dosing depends on severity of hypokalemia and patient response. * **Intravenous (IV):** * Dosage is highly individualized based on serum potassium levels and clinical status. * Concentration: Maximum concentration usually 40 mEq/L. * Rate: Maximum infusion rate typically 0.5 mEq/kg/hour to 1 mEq/kg/hour. Higher rates may be used in emergent situations with continuous ECG monitoring. Dosing depends on severity of hypokalemia and patient response. ### Dose Adjustments * **Renal Impairment:** Use with extreme caution. Potassium accumulation can occur, leading to hyperkalemia. Dosing should be guided by serum potassium levels and renal function. * **Hepatic Impairment:** No specific adjustments, but monitor for electrolyte imbalances. ### Contraindications * Hyperkalemia. * Conditions that may predispose to hyperkalemia (e.g., renal failure, untreated Addison's disease, severe tissue trauma). * Certain medications (e.g., potassium-sparing diuretics, ACE inhibitors, ARBs, NSAIDs) can increase potassium levels and should be used cautiously or avoided. ### Adverse Effects * **Common:** Nausea, vomiting, diarrhea, abdominal pain (oral). Phlebitis, pain at injection site, venous irritation (IV). * **Serious:** Hyperkalemia (risk increases with dose, renal impairment, and concurrent use of other potassium-increasing drugs), cardiac arrhythmias, cardiac arrest. ### Key Drug Interactions * **Potassium-sparing diuretics (e.g., spironolactone, amiloride):** Increased risk of hyperkalemia. * **ACE inhibitors (e.g., lisinopril), ARBs (e.g., losartan), NSAIDs (e.g., ibuprofen):** Increased risk of hyperkalemia. * **Digoxin:** Hyperkalemia can increase digoxin toxicity; hypokalemia can increase risk of arrhythmias. * **Other potassium-containing products:** Increased risk of hyperkalemia. ### Monitoring * Serum potassium levels (frequently, especially during IV therapy and dose adjustments). * Renal function (BUN, creatinine). * ECG (especially with rapid IV infusion or history of cardiac issues). * Signs and symptoms of hypokalemia and hyperkalemia. ### Clinical Pearls * Oral potassium chloride can be irritating to the gastrointestinal tract. Administer with food or fluids to minimize GI upset. * Dilute liquid or crushed tablet formulations appropriately when administering orally. * IV potassium administration requires careful attention to concentration and infusion rate to prevent life-threatening hyperkalemia and cardiac complications. * Always verify serum potassium levels and clinical status before initiating or adjusting potassium therapy. * Specific IV infusion protocols may vary based on institutional guidelines and patient acuity. *** *This information is intended for healthcare professionals. Always consult the official prescribing information and your institution's protocols for the most current and complete drug information.*